{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T13:01:09Z","timestamp":1769346069772,"version":"3.49.0"},"reference-count":24,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:p>Deficiency of adenosine deaminase 2 (DADA2) is a rare autoinflammatory disease that was firstly described in patients with early-onset strokes, livedo reticularis, and periodic fever resembling polyarteritis nodosa. In reported case series, researchers described highly variable manifestations, including autoimmunity, immunodeficiency, hepatosplenomegaly, pancytopenia, ichthyosiform rash, and arthritis, in patients with DADA2. A thirteen-year-old female patient who was born to consanguineous parents was admitted to our hospital with generalized edema and leg pain. A physical examination revealed splenomegaly and left knee arthritis. Nephrotic-range proteinuria and hypoalbuminemia were present, and a renal biopsy revealed amyloidosis. Despite the absence of periodic fever and livedo reticularis, our patient had suggestive features of DADA2, including low serum immunoglobulin G and immunoglobulin M levels, hepatosplenomegaly, and renal amyloidosis. We found a heterozygote Met694Val mutation in the Mediterranean fever gene and a novel homozygote Thr317Argfs*25 (c.950-950delCys) mutation in the cat eye chromosome region 1 gene. A functional analysis revealed absent plasma adenosine deaminase 2 activity. Canakinumab was administered because of unresponsive proteinuria despite 2 months of treatment with colchicine and methylprednisolone. Proteinuria improved after 7 doses of canakinumab. In conclusion, DADA2 should be considered in the differential diagnosis of renal amyloidosis, particularly in the absence of homozygote Mediterranean fever mutations. Although anti\u2013tumor necrosis factor agents are widely offered in DADA2 treatment, we speculate that canakinumab may be an appropriate treatment of renal amyloidosis in DADA2.<\/jats:p>","DOI":"10.1542\/peds.2018-0948","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T07:27:59Z","timestamp":1540884479000},"source":"Crossref","is-referenced-by-count":24,"title":["Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab"],"prefix":"10.1542","volume":"142","author":[{"given":"Rabia Miray","family":"Kisla Ekinci","sequence":"first","affiliation":[{"name":"Departments of Pediatric Rheumatology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"Balci","sequence":"additional","affiliation":[{"name":"Departments of Pediatric Rheumatology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atil","family":"Bisgin","sequence":"additional","affiliation":[{"name":"Medical Genetics,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hershfield","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biochemistry, School of Medicine, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahriye","family":"Atmis","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Dogruel","sequence":"additional","affiliation":[{"name":"Pediatric Allergy and Immunology, Faculty of Medicine, \u00c7ukurova University, Adana, Turkey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Departments of Pediatric Rheumatology,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"issue":"10","key":"2021120916234490800_B1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2.","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120916234490800_B2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-017-3740-3","article-title":"Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.","volume":"38","author":"Sahin","year":"2018","journal-title":"Rheumatol Int"},{"issue":"10","key":"2021120916234490800_B3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"2021120916234490800_B4","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases.","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2021120916234490800_B5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10875-016-0245-x","article-title":"Deficiency of adenosine deaminase 2 causes antibody deficiency.","volume":"36","author":"Schepp","year":"2016","journal-title":"J Clin Immunol"},{"issue":"11","key":"2021120916234490800_B6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","article-title":"Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa.","volume":"151","author":"Gonzalez Santiago","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2021120916234490800_B7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the clinical phenotype of adenosine deaminase 2 deficiency.","volume":"177","author":"Ben-Ami","year":"2016","journal-title":"J Pediatr"},{"issue":"10","key":"2021120916234490800_B8","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2021120916234490800_B9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12969-017-0193-x","article-title":"Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.","volume":"15","author":"Skrabl-Baumgartner","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"2021120916234490800_B10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","article-title":"Monogenic polyarteritis: the lesson of ADA2 deficiency.","volume":"14","author":"Caorsi","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"2021120916234490800_B11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00431-014-2320-8","article-title":"Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.","volume":"173","author":"Garg","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"4","key":"2021120916234490800_B12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2015.07.053","article-title":"IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.","volume":"137","author":"Fellmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2021120916234490800_B13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.","volume":"55","author":"Van Montfrans","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"2021120916234490800_B14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3899\/jrheum.150024","article-title":"A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations.","volume":"42","author":"Batu","year":"2015","journal-title":"J Rheumatol"},{"issue":"7","key":"2021120916234490800_B15","doi-asserted-by":"crossref","first-page":"e68431","DOI":"10.1371\/journal.pone.0068431","article-title":"The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach.","volume":"8","author":"J\u00e9ru","year":"2013","journal-title":"PLoS One"},{"key":"2021120916234490800_B16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.gene.2017.10.068","article-title":"Genotype-phenotype correlation in FMF patients: a \u201cnon classic\u201d recessive autosomal or \u201catypical\u201d dominant autosomal inheritance?","volume":"641","author":"Procopio","year":"2018","journal-title":"Gene"},{"issue":"6","key":"2021120916234490800_B17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/jhg.2010.52","article-title":"Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations.","volume":"55","author":"Moradian","year":"2010","journal-title":"J Hum Genet"},{"issue":"4","key":"2021120916234490800_B18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","article-title":"A new set of criteria for the diagnosis of familial Mediterranean fever in childhood.","volume":"48","author":"Yal\u00e7inkaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2021120916234490800_B19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of familial Mediterranean fever.","volume":"40","author":"Livneh","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2021120916234490800_B20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/ket400","article-title":"Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study.","volume":"53","author":"Kasifoglu","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2021120916234490800_B21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00296-017-3796-0","article-title":"Familial Mediterranean fever in childhood: a single-center experience.","volume":"38","author":"Barut","year":"2018","journal-title":"Rheumatol Int"},{"issue":"7","key":"2021120916234490800_B22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00296-014-3205-x","article-title":"Predictors of AA amyloidosis in familial Mediterranean fever.","volume":"35","author":"Mukhin","year":"2015","journal-title":"Rheumatol Int"},{"issue":"1","key":"2021120916234490800_B23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autrev.2012.07.019","article-title":"Familial Mediterranean fever: new phenotypes.","volume":"12","author":"Soriano","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2021120916234490800_B24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejmg.2016.12.003","article-title":"The M694I\/M694I genotype: a genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever.","volume":"60","author":"Ait-Idir","year":"2017","journal-title":"Eur J Med Genet"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-0948\/1066889\/peds_20180948.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-0948\/1066889\/peds_20180948.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T04:36:21Z","timestamp":1639110981000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/142\/5\/e20180948\/38562\/Renal-Amyloidosis-in-Deficiency-of-Adenosine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,11,1]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2018-0948","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"article-number":"e20180948"}}